New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Last updated: October 24, 2026 3:30 pm

The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Source: Wired

Share This Article

ByThe True Post

The newsroom of The True Post.

Top Stories

Mourinho primes Madrid for statement win over Barça to blow LaLiga title race wide open

Larson extends points lead with first NASCAR win at Talladega after last-lap scramble

James Gunn Defends the DC Universe, Says He Dislikes the Idea That ‘Individual Stories Aren’t Meaningful Unless They Lead to Something’

Stay Connected

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

Leave a Reply Cancel reply

Related Stories

Apple Intelligence is finally coming to China, but without Siri AI

Someone got Doom in an SQL database

Inside the mini factory where GM builds its EV future

I only bought Pokémon Legends: Z-A during Prime Day, and it’s still on sale

Samsung Galaxy A36's One UI 9 update lands in Europe

I Put the Oppo Find X10 Pro’s Camera to the Test. These Are the Results

Away’s New Series 3 Luggage Plays It Safe—That’s the Point

The next-gen Xbox won’t cost you $1,800. It can’t. Can it?

Sections

The Newsroom